Gemcitabine and vinorelbine in patients with advanced lung cancer preclinical studies and report of a phase I trial

Cancer Chemotherapy and Pharmacology

Volumn 48, Issue 2, 2001, Pages 151-159

  Herhst, R S ^a   Lynch, C ^a   Vasconcelles, M ^a   Teicher, B A ^a   Strauss, G ^a   Elias, A ^a   Anderson, I ^a   Zacarola, P ^a   Dang, Nam H ^b   Leong, Traci ^b   Salgia, Ravi ^b   Skarin, Arthur T ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b Department of Biostatistics ^*  (United States)

Author keywords

Combination therapy; Gemcitabine; Non small cell lung cancer; Preclinical studies; Vinorelbine

Indexed keywords

GEMCITABINE; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FATIGUE; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MAXIMUM TOLERATED DOSE; MOUSE; NAUSEA; NEUTROPENIA; NONHUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0034896060     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800100282     Document Type: Article

References (34)

1. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology
2. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group
3. Randomized phase III trial comparing cisplatin/etoposide versus carboplatin/paclitaxel in advanced and metastatic non-small cell lung cancer
4. In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence
5. Phase III trial comparing etoposide-cisplatin versus taxol with cisplatin-G-CSF versus taxol-cisplatin in advanced non-small cell lung cancer
6. Overview of chemotherapy for small cell lung cancer
7. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer
8. Modified weekly regimen with vinorelbine as a single agent in unresectable non-small cell lung cancer
9. A randomized trial of gemcitabine cisplatin versus mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer. A multicenter phase III study
10. Isobologram analysis of X-ray-BCNU interactions in vitro
11. A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer
12. A phase I study of gemcitabine/cisplatin/etoposide in the treatment of small-cell lung cancer
13. Promising new agents in the treatment of non-small cell lung cancer
14. New drugs for treating small cell lung cancer
15. A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group
16. Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group
17. Current status and novel therapeutic approaches in advanced non-small cell lung cancer
18. Cancer statistics, 2000
19. Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: A phase II study. Gruppo Oncologico Centro-Sud-Isole
20. Chemotherapy of advanced non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
21. Gemcitabine and vinorelbine in advanced non-small cell lung carcinoma: A phase II study
22. Synthesis of 2-deoxy-2′,2′-difluoro-D-ribose and 2-deoxy-2′,2′-difluoro-D-ribofuranosyl nucleosides
23. Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro-2′-deoxycytidine)
24. Phase I study of vinorelbine and paclitaxel in small-cell lung cancer
25. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients
26. Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer
27. Vinorelbine as single-agent chemotherapy in advanced non-small cell lung cancer
28. Evaluation of new drugs in small cell lung cancer: The activity of gemcitabine
29. The synthesis of Navelbine prototype of a new series of vinblastine derivatives
30. Phase III study of cisplatin with or without gemcitabine in patients with advanced non-small cell lung cancer
31. Phase II trials of single-agent activity of gemcitabine in patients with advanced non-small cell lung cancer: An overview
32. Chemotherapeutic potentiation through interaction at the level of DNA
33. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents
34. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study